Video
In Conversation with Charles River
A year on from the announcement of our strategic partnership with Charles River, we sat down with Dr Marijn Vlaming, Head of Biology, to discuss how ioCells are accelerating drug discovery and early-stage development.
Discover our ioCells portfolio
A year on from the announcement of our strategic partnership with Charles River, we sat down with Dr Marijn Vlaming, Head of Biology, to discuss how ioCells are accelerating drug discovery and early-stage development.
bit.bio and Charles River have partnered for translational drug development. Learn how you can screen and profile at Charles River with bit.bio ioCells.
Find out how ioCells can accelerate your drug discovery:
- ioCells arrive at your lab with minimal batch to batch variation providing high reproducibility
- ioCells accelerate drug discovery as they rapidly mature and are ready for experimentation within days
- Using our two-step protocol means less time being spent on cell culture and more time gaining results